Search

Author/Creator Fuchs, Charles S.

31. Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance). Issue 2 (9th August 2022)

Authors:
Brown, Justin C.; Ma, Chao; Shi, Qian; Fuchs, Charles S.; Meyer, Jeffrey; Niedzwiecki, Donna; Zemla, Tyler; Couture, Felix; Kuebler, Philip; Kumar, Pankaj; Lewis, DeQuincy; Tan, Benjamin; Krishnamurthi, Smitha; O'Reilly, Eileen M.; Shields, Anthony F.; Meyerhardt, Jeffrey A.
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 2(2023)
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

32. Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer. (21st February 2013)

Authors:
Lee, Michael S.; Mamon, Harvey J.; Hong, Theodore S.; Choi, Noah C.; Fidias, Panagiotis M.; Kwak, Eunice L.; Meyerhardt, Jeffrey A.; Ryan, David P.; Bueno, Raphael; Donahue, Dean M.; Jaklitsch, Michael T.; Lanuti, Michael; Rattner, David W.; Fuchs, Charles S.; Enzinger, Peter C.
Journal:
Oncologist
Issue:
Volume 18:Number 3(2013)
Page Start:
281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

33. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. (April 2019)

Authors:
Kosumi, Keisuke; Hamada, Tsuyoshi; Zhang, Sui; Liu, Li; da Silva, Annacarolina; Koh, Hideo; Twombly, Tyler S.; Mima, Kosuke; Morikawa, Teppei; Song, Mingyang; Nowak, Jonathan A.; Nishihara, Reiko; Saltz, Leonard B.; Niedzwiecki, Donna; Ou, Fang-Shu; Zemla, Tyler; Mayer, Robert J.; Baba, Hideo; Ng...
Journal:
European journal of cancer
Issue:
Volume 111(2019)
Page Start:
82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

34. Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor‐infiltrating lymphocyte levels. Issue 11 (27th November 2022)

Authors:
Ugai, Tomotaka; Liu, Li; Tabung, Fred K.; Hamada, Tsuyoshi; Langworthy, Benjamin W.; Akimoto, Naohiko; Haruki, Koichiro; Takashima, Yasutoshi; Okadome, Kazuo; Kawamura, Hidetaka; Zhao, Melissa; Kahaki, Seyed Mostafa Mousavi; Glickman, Jonathan N.; Lennerz, Jochen K.; Zhang, Xuehong; Chan, Andrew ...
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 11(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Issue 9 (19th June 2015)

Authors:
Campa, Daniele; Rizzato, Cosmeri; Stolzenberg‐Solomon, Rachael; Pacetti, Paola; Vodicka, Pavel; Cleary, Sean P.; Capurso, Gabriele; Bueno‐de‐Mesquita, H. B(as); Werner, Jens; Gazouli, Maria; Butterbach, Katja; Ivanauskas, Audrius; Giese, Nathalia; Petersen, Gloria M.; Fogar, Paola; Wang, Zhaoming...
Journal:
International journal of cancer
Issue:
Volume 137:Issue 9(2015:Nov. 01)
Page Start:
2175
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

38. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. (3rd July 2018)

Authors:
Hamada, Tsuyoshi; Soong, Thing Rinda; Masugi, Yohei; Kosumi, Keisuke; Nowak, Jonathan A.; da Silva, Annacarolina; Mu, Xinmeng Jasmine; Twombly, Tyler S.; Koh, Hideo; Yang, Juhong; Song, Mingyang; Liu, Li; Gu, Mancang; Shi, Yan; Nosho, Katsuhiko; Morikawa, Teppei; Inamura, Kentaro; Shukla, Sachet ...
Journal:
Oncoimmunology
Issue:
Volume 7:Number 7(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

39. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

40. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Issue 24 (1st October 2013)

Authors:
Fuchs, Charles S.; Fakih, Marwan; Schwartzberg, Lee; Cohn, Allen L.; Yee, Lorrin; Dreisbach, Luke; Kozloff, Mark F.; Hei, Yong‐jiang; Galimi, Francesco; Pan, Yang; Haddad, Vincent; Hsu, Cheng‐Pang; Sabin, Antony; Saltz, Leonard
Journal:
Cancer
Issue:
Volume 119:Issue 24(2013)
Page Start:
4290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗